ASX Announcements

 

Date	Part	Topic
20 November 2013		Results of Meeting
20 November 2013		Final Director's Interest Notice
20 November 2013		Director's resignation
20 November 2013		Managing Director's AGM presentation
20 November 2013		Chairman's address to shareholders
18 November 2013		IDT files ANDA for Temozolomide in the US
28 October 2013		Investor Presentation Biotech Invest 2013
25 October 2013		Change in substantial holding
22 October 2013		Change of Director's Interest notice
22 October 2013		Change of Director's Interest notice
21 October 2013		Change in substantial holding
21 October 2013		Change in substantial holding
21 October 2013		Change in substantial holding
21 October 2013		Notice of AGM / Proxy Form
18 October 2013		Appendix 3B
17 October 2013		Notice under sec708(5)(e) Corps Act 2001
17 October 2013		Placement completion
09 October 2013		Results of General Meeting
02 October 2013		Change of Director's Interest notice
02 October 2013		Change of Director's Interest notice
27 September 2013		Rights Issue shortfall Notice
24 September 2013		Annual Report 2013
6 September 2013		Notice of General Meeting / Proxy Form
30 August 2013		Rights Issue Offer Booklet
29 August 2013		Appendix 3B
29 August 2013		Cleansing Statement under s708AA
29 August 2013		Non renounceable rights issue & placement
29 August 2013		Preliminary Final Report
22 August 2013		Board changes and renewal
16 August 2013		Investor Presentation
9 July 2013		Business Update July 2013
10 May 2013		Appendix 3B
10 May 2013		Cleansing Notice
10 May 2013		Completion of Placement to I'rom Holdings Co., Ltd
07 May 2013		Strategic Cornerstone Placement
16 April 2013		Appendix 3B
16 April 2013		Business Update
03 April 2013		Appointment of CEO
01 Mar 2013		Final director's Interest notice
26 Feb 2013		Appendix 4D
26 Feb 2013		Half Yearly Report & Accounts
14 December 2012		CEO Resignation
28 August 2012		2012 Appendix 4E
20 March 2012		Director Appointment / Resignation
17 February 2012		Appendix 4D
17 February 2012		Half yearly report
27 April 2011		Market update
23 February 2011		Half year accounts
23 February 2011		Lapse of unlisted bonus options
23 February 2011		Appendix 4D
10 January 2011		Profit guidance and business update
10 January 2011		Appointment of new director
04 November 2010		Results of meeting
04 November 2010		Managing Director's Powerpoint Presentation
04 November 2010		Chairman & Managing Director's Address at AGM
27 September 2010		Annual Report
27 September 2010		Notice of Meeting and Proxy Form
01 September 2010		Preliminary Final report
30 April 2010		Change of Directors Interest Notice (x6)
30 April 2010		Confirmation of Allotment of Bonus Options
14 April 2010		Bonus Option Offer Prospectus
12 April 2010		ASX Release
06 April 2010		Appendix 3B
06 April 2010		Response to a ASX Price Query
05 March 2010		SandP Announces March SP/ASX Index Rebalance
18 February 2010		Appendix 3B
16 February 2010		Half Yearly Reports and Accounts
30 October 2009		Managing Director Powerpoint Presentation
30 October 2009		Chairman`s and Managing Directors Address at AGM
30 October 2009		Results of meeting
29 September 2009		Annual Report
29 September 2009		Notice of Meeting and Proxy Form
18th August 2009		Preliminary Final Report
29 April 2009		Change of Director's Interest Notice
06 March 2009		SandP Announces March SP/ASX Index Rebalance
17 February 2009		Half Yearly Report and Accounts
23 December 2008		Market update
31 October 2008		Results of meeting
31 October 2008		Chairman's address to Shareholders
14 October 2008		Change of Director`s Interest Notice
14 October 2008		Change in substantial holding
13 October 2008		Ceasing to be a substantial holder from ANZ
30 September 2008		Notice of Annual General Meeting
30 September 2008		Proxy Form
30 September 2008		Annual Report
03 September 2008		Change of Director's Interest Notice
01 September 2008		Change of Director`s Interest Notice
28 August 2008		Change in substantial holding
15 August 2008		Preliminary final report
11 August 2008		IDT Facility Opening
21 July 2008		Change in substantial holding
21 July 2008		Change of Director's Interest Notice
9 July 2008		Response to an ASX Query re Margin Lending Facilities
8 July 2008		ANZ: Primebroker Disclosure
8 July 2008		Trading Halt Request
12 May 2008		Form 603 and 604 from ANZ
19 February 2008		Half Yearly Report and Accounts
02 January 2008		Initial Director's Interest Notice
26 October 2007		Constitution
26 October 2007		Results of Meeting
26 October 2007		Chairman's Address to Shareholders
26 October 2007		Chairman's Address to Shareholders
11 October 2007		Reply to ASX Price Query
24 September 2007		Notice of Annual General Meeting
24 September 2007		Proxy Form
24 September 2007		Annual Report
14 August 2007		Preliminary final report
6 August 2007		Appendix 3B - New Issue Announcement
20 February 2007		Half Yearly Report & Half Yearly Accounts
25 January 2007		IDT Expands Drug Development Relationship with Pfizer
12 December 2006		Response to ASX Query re Share Price
27 October 2006		Final Director's Interest Notice
27 October 2006		AGM Meeting
27 October 2006		AGM Chairman Presentation
27 October 2006		AGM Chairman Presentation
27 September 2006		Retirement of Director
26 September 2006		Notice of Annual General Meeting
26 September 2006		Proxy Form
26 September 2006		Annual Report
22 August 2006		Change of Directors Interest Notice
16 August 2006		Appendix 3B - New Issue Announcement
15 August 2006		Preliminary final report
07 June2006		Change of Director's Interest Notice 2
31 May 2006		Change of Director's Interest Notice 2
30 May 2006		Change of Director's Interest Notice 2
23 February 2006		Half Yearly Report & Half Yearly Accounts
27 January 2006		Change of Director's Interest
17 February 2006		Ceasing to be a substantial holder from AMP
24 January 2006		Change of Director's Interest